日本語 
Pharma
Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd. to roll out a generative AI solution that supports the creation of regulatory documents in drug development. The…
Re-air Raises ¥580M for Vascular Regeneration Therapy
Tokyo biotech startup Reair Inc., which spun out from Juntendo University, has…
BlueMeme Invests in MediVally for Medical Innovation
BlueMeme Partners Inc., a group company of BlueMeme Inc., is pleased to…
Elix, LINC Launch First AI Drug Platform with Fed Learning
Elix, Inc. and the Life Intelligence Consortium (LINC) have launched the world’s…
Verified Clinical Trials launches in Japan to curb duplicates
Verified Clinical Trials (VCT) is now operating in Japan. They teamed up…
Chugai and Gero Join Forces on Aging Disease Therapies
Chugai Pharmaceutical Co., Ltd. and Singapore-based biotechnology firm Gero PTE. LTD. Gero…
Elix and LINC Unveil AI Drug Platform Using Pharma Data
Elix Inc. and the Life Intelligence Consortium (LINC), a general incorporated association…
Actair® Promotion in Japan Transitions to CEOLIA Pharma
Stallergenes Greer, together with Shionogi & Co., Ltd. and CEOLIA Pharma Co.,…
Alpha Fusion, Curadh MTR Partner on Astatine-211 Drugs
Alpha Fusion, Inc. and Curadh MTR, Inc. They plan to create a…
English